title: Secretion of growth hormone-releasing hormone in patients with idiopathic pituitary dwarfism and acromegaly.
abstract: The plasma levels of immunoreactive-GHRH in patients with idiopathic pituitary dwarfism and acromegaly were studied in the basal state and during various tests by a sensitive and specific RIA. The fasting plasma GHRH level in 22 patients with idiopathic pituitary dwarfism was 6.3 +/- 2.3 ng/l (mean +/- SD), which was significantly lower than that in normal children (9.8 +/- 2.8 ng/l, N = 21), and eight of them had undetectable concentrations (less than 4.0 ng/l). Little or no response of plasma GHRH to oral administration of L-dopa was observed in 7 of 10 pituitary dwarfs, and 3 of the 7 patients showed a response of plasma GH to iv administration of GHRH (1 microgram/kg). These findings suggest that one of the causes of idiopathic pituitary dwarfism is insufficient GHRH release from the hypothalamus. The fasting plasma GHRH level in 14 patients with acromegaly and one patient with gigantism was 8.0 +/- 3.9 ng/l, which was slightly lower than that in normal adults (10.4 +/- 4.1 ng/l, N = 72). One acromegalic patient with multiple endocrine neoplasia type I had a high level of plasma GHRH (270 ng/l) with no change in response to L-dopa and TRH test. In 3 untreated patients with acromegaly L-dopa did not induce any response of plasma GHRH in spite of inconsistent GH release, and in 4 patients with acromegaly, TRH evoked no response of plasma GHRH in spite of a marked GH release, suggesting that the GH responses are not mediated by hypothalamic GHRH.(ABSTRACT TRUNCATED AT 250 WORDS)
mesh_terms: D000172:Acromegaly / Q000097:blood / Q000503:physiopathology*; D000293:Adolescent; D002648:Child; D004393:Dwarfism, Pituitary / Q000503:physiopathology*; D005215:Fasting; D005260:Female; D013006:Growth Hormone / Q000097:blood; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D009377:Multiple Endocrine Neoplasia / Q000097:blood / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000097:blood / Q000378:metabolism; D011863:Radioimmunoassay; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage
chemical_list: D007980:Levodopa; D013973:Thyrotropin-Releasing Hormone; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone